PLOD1 and hyperuricemia: Among postmenopausal women, after adjusting for the same variables, participants in the fourth quartile of DHEA, TT, and LH had odds of hyperuricemia that were significantly increased by 155% (OR 2.55, 95% CI 1.58, and 4.13), 99% (OR 1.99, 95% CI 1.18, and 3.33), and 76% (OR 1.76, 95% CI 1.05, and 2.94), respectively (all P < 0.05).